Geneticin shows selective antiviral activity against SARS-CoV-2 by interfering with programmed −1 ribosomal frameshifting

Mostrar otras versiones (1)

SARS-CoV-2 is currently causing an unprecedented pandemic. While vaccines are massively deployed, we still lack effective large-scale antiviral therapies. In the quest for antivirals targeting conserved structures, we focused on molecules able to bind viral RNA secondary structures. Aminoglycosides...

Descripción completa

Detalles Bibliográficos
Autores principales: Varricchio, Carmine, Mathez, Gregory, Pillonel, Trestan, Bertelli, Claire, Kaiser, Laurent, Tapparel, Caroline, Brancale, Andrea, Cagno, Valeria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier B.V. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9617636/
https://www.ncbi.nlm.nih.gov/pubmed/36341734
http://dx.doi.org/10.1016/j.antiviral.2022.105452

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9617636/
https://www.ncbi.nlm.nih.gov/pubmed/36341734
http://dx.doi.org/10.1016/j.antiviral.2022.105452

Ejemplares similares